Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
The present invention discloses compounds according to Formula I: Wherein R 1a , R 1b , R 2 , R 4 , R 5 , R 6a , R 6b , R 7 , R 8 , W, X, Cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (NPP2 or ENPP2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving fibrotic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, respiratory diseases, cardiovascular diseases, neurodegenerative diseases, dermatological disorders, and/or abnormal angiogenesis associated diseases by administering the compound of the invention.
1. A process for preparing a compound of formula G:
comprising the steps of
(a) reacting a compound of formula C with Boc-piperazine to form a compound of formula
(b) reacting a compound of formula D with HCl to form a compound of formula
and,
(c) reacting a compound of formula E with a compound of formula
2. The process of claim 1 further comprising step (d) reacting a compound of formula
with a compound of formula
to form a compound of formula
3. The process of claim 2 further comprising the step of obtaining the compound of formula (B) by reacting 4-fluorobenzoylacetonitrile with thiourea to obtain 2-Amino-4-(4-fluoro-phenyl)-thiazole-5-carbonitrile, and, 2-Amino-4-(4-fluoro-phenyl)-thiazole-5-carbonitrile transformed into the compound of formula (B) by an aminodisplacement reaction.